PRKD1 Gene Congenital heart defects and ectodermal dysplasia Genetic Test
Genetic testing plays a crucial role in identifying and managing various genetic conditions. One such test is the PRKD1 Gene Congenital heart defects and ectodermal dysplasia Genetic Test offered by DNA Labs UAE.
Test Name: PRKD1 Gene Congenital heart defects and ectodermal dysplasia Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
Pre Test Information:
Before undergoing the PRKD1 Gene Congenital heart defects and ectodermal dysplasia NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by PRKD1 Gene Congenital heart defects and ectodermal dysplasia NGS Genetic DNA Test gene PRKD1.
Test Details:
The PRKD1 gene is associated with a condition called congenital heart defects and ectodermal dysplasia (CHDFED). This condition is characterized by the presence of heart abnormalities and abnormalities in the development of the skin, hair, teeth, and sweat glands.
NGS genetic testing, also known as Next-Generation Sequencing, is a high-throughput method used to sequence large amounts of DNA. In the context of CHDFED, NGS genetic testing can analyze the PRKD1 gene and identify any mutations or variations that may be present.
By identifying mutations in the PRKD1 gene, NGS genetic testing can help diagnose CHDFED and provide valuable information for genetic counseling and management of the condition. It can also be used for carrier testing in families with a history of CHDFED to determine the risk of passing the condition on to future generations.
Overall, NGS genetic testing for the PRKD1 gene in CHDFED can aid in early diagnosis, appropriate medical management, and informed family planning decisions.
| Test Name | PRKD1 Gene Congenital heart defects and ectodermal dysplasia Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PRKD1 Gene Congenital heart defects and ectodermal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRKD1 Gene Congenital heart defects and ectodermal dysplasia NGS Genetic DNA Test gene PRKD1 |
| Test Details |
The PRKD1 gene is associated with a condition called congenital heart defects and ectodermal dysplasia (CHDFED). This condition is characterized by the presence of heart abnormalities and abnormalities in the development of the skin, hair, teeth, and sweat glands. NGS genetic testing refers to Next-Generation Sequencing, a high-throughput method used to sequence large amounts of DNA. In the context of CHDFED, NGS genetic testing can be used to analyze the PRKD1 gene and identify any mutations or variations that may be present. By identifying mutations in the PRKD1 gene, NGS genetic testing can help diagnose CHDFED and provide valuable information for genetic counseling and management of the condition. It can also be used for carrier testing in families with a history of CHDFED to determine the risk of passing the condition on to future generations. Overall, NGS genetic testing for the PRKD1 gene in CHDFED can aid in early diagnosis, appropriate medical management, and informed family planning decisions. |
